Defining Signaling Networks - Functional PTMs

Program

• • Poster presentation
  • P-I-0001

  Phosphoproteomic alterations in Mesenchymal stem cells induced by Dimethyl fumarate treatment

  • Maryam Adelipour (Daejeon / KR)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0002

  Insights into phosphorylation post-translational modifications in the proteome of C. albicans during oxidative stress response

  • Víctor Arribas (Madrid / ES)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0003

  Using phosphoproteomics to explore autophagy relevant TBK1 signal transduction

  • Ibrahim Bayramoglu (Fribourg / CH)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0004

  Active oxidative metabolism and impaired glyoxalase system amid elevated intracellular oxidative stress in non-small cell lung cancer shown by immediate post surgery alkylation and redox proteomics

  • Ruth Birner-Grünberger (Vienna / AT)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0005

  Proteome-wide in vitro kinase and phosphatase assays to determine enzyme-substrate interactions

  • Melanie Brunner (Fribourg / CH)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0006

  Proteomic and phosphoproteomic characterization of FFPE lung adenocarcinoma harboring ALK, EGFR or KRAS Mutations, and triple wild-type tissue sections

  • Fanni Bugyi (Budapest / HU)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0007

  Functional phosphoproteomics and network models to elucidate mechanisms of deregulated signaling

  • Mira Lea Burtscher (Heidelberg / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0008

  Dissecting the spatiotemporal regulation of the cell cycle using phosphoproteomics and highlighting functional differences within proteoform families

  • Anthony Cesnik (Stanford, CA / US)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0009

  Simultaneous profiling of sialoglycoproteome and phosphoproteome in TKI-resistant NCSLC cells using metal ion-decorated ZIC-cHILIC StageTip

  • Yi-Ju Chen (Taipei / TW)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0010

  A multi-proteomics analysis of FGFR family mutations on cancer signalling networks

  • Iftekhar Mahmud Chowdhury (Helsinki / FI)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0011

  Traceability of post-translational modifications in atherosclerosis from plasma to tissue to single-cell proteomics

  • David del Rio Aledo (Madrid / ES)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0012

  Mass spectrometry analysis of post translational modification in adeno-associated virus capsid proteins

  • Vrushali Deshpande (Bangalore / IN)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0013

  The regulatory role of CARP-NF-κB in breast cancer metastasis

  • Penchatr Diskul Na Ayudthaya (Bangkok / TH)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0014

  Light changes promote distinct responses of plastid protein acetylation marks in the model plant Arabidopsis thaliana

  • Juergen Eirich (Muenster / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0015

  Effect of lysine post-translational modifications in the proteome of extracellular vesicles from non-small cell lung cancer cells

  • Sergio Manuel Encarnación-Guevara (Cuernavaca / MX)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0016

  Exploring EGFR and MET cross-talk in NSCLC: a pathway to improved therapy efficacy

  • Dario Frey (Heidelberg / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0017

  Phosphotyrosine-based phosphoproteomics scaled down to sub-mg needle biopsy level for analysis of individual tumor biology and treatment selection

  • Alex Henneman (Amsterdam / NL)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0018

  Deciphering the signaling mechanisms of the C-type lectin receptor Dectin-1 in myeloid cells using high throughput proteomics

  • Anne Gonzalez de Peredo (Toulouse / FR)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0019

  Hydrogen sulfide signalling as an additional factor to sex-related differences in ALS progression

  • Viviana Greco (Rome / IT)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0020

  A targeted proteomic approach to assess the presence of mouse-specific histone H3 variants in brain and testis

  • Hassan Hijazi (Grenoble / FR)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0021

  Single-shot tyrosine phosphoproteomics through FAIMS-DIA, and FAIMS-PRM mass-spectrometry afterwards, in revealing the signaling networks associated with BTKi-mediated drug mechanism of action

  • Mahmud Hossain (Cambridge, MA / US)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0022

  Redox proteome analysis of rat liver: gender-specific effects to diet and aging

  • Isabel Huber (Potsdam / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0023

  A pharmacological dimension to personalised phosphoproteomics of human skeletal muscle

  • Hannah Huckstep (Melbourne / AU)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0024

  Analysing non-proteinaceous ubiquitination via NoPro-clipping

  • Marco Jochem (Parkville / AU)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0025

  Accelerating single-shot phosphoproteomics by identification and quantitation of > 100,000 phosphosites in human cell lines

  • Claire Koenig (Copenhagen / DK)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0026

  Comparison of phosphopeptide enrichment and LC-MS/MS acquisition methods to study cancer phosphoproteome

  • Petr Lapcik (Brno / CZ)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0027

  Posttranslational modification of angiotensin II by pyridoxal-5'-phosphate as a new drug approach against high blood pressure

  • Michaela Lellig (Aachen / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0028

  Deciphering the role of ADP-ribosylation in CardioLaminopathy

  • Deena Leslie Pedrioli (Zurich / CH)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0029

  Secretome and degradome analysis reveal effects of Kallikrein-related peptidase 6 on ECM arrangement and immune recognition in PDAC

  • Mujia Li (Freiburg / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0030

  SICyLIA-TMT: a multi-step labelling strategy for global redox proteomics

  • Sergio Lilla (Glasgow / GB)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0031

  A dynamic interaction landscape of the mammalian Hh signaling pathway

  • Xiaonan Liu (Helsinki / FI)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0032

  Delineating organ phosphoproteomic landscapes and deregulated metabolic associated signaling under dietary intervention

  • Ziliang Ma (Utrecht / NL)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0033

  Comparative quantitative proteome and phosphoproteome analysis of castor bean (Ricinus communis L.) seed endosperm at different imbibition stages

  • Yara Martins da Silva (Rio de Janeiro / BR)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0034

  The phosphoproteome of stress granules

  • Sophie Moggridge (Seattle, WA / US)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0035

  Defining intracellular and extracellular role of AGR2: insights of from CRISPR-targeted breast cancer cells and DIA-NN analysis

  • M. Aiman Mohtar (Kuala Lumpur / MY)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0037

  Comprehensive analysis of the redox proteome reveals survival pathways activated upon resistance to Pevonedistat

  • Michaela Myšáková (Prague / CZ)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0038

  Proteomic characterization of the protein S-glutathionylation pattern in stem and leukemic cells

  • Dušan Němec (Vestec / CZ)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0039

  PM2.5 engages impairment of mucosal immunity, involving alteration of complement activation and cell junction assembly by regulated IL-17 levels: Pathological and proteomic approaches

  • Warat Palpai (Samut Prakan / TH)
  • Thamradee Tansrivorarat (Samut Prakan / TH)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0040

  Redox proteomics identifies a novel adaptive mechanism of leukemic cells emerging upon exposure to hypomethylation therapy

  • Kristýna Pimková (Vestec / CZ)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0041

  Histone variants and post-translational modifications in the regulation of plant callus formation

  • Pavlína Pírek (Brno / CZ)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0042

  Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing

  • Anastasia Piskopou (Utrecht / NL)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0043

  Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties

  • Gabriela Prus (Copenhagen / DK)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0044

  Proteomic workflows for substrate screening and site mapping of ubiquitin-like protein modification

  • Elena Rudashevskaya (Goettingen / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0045

  Proteomic and phosphoproteomic profiling of a TRIB2-KO glioblastoma-derived cell line reveals new roles in cell signaling

  • Pablo San Segundo Acosta (Madrid / ES)
  • Rodrigo Barderas (Madrid / ES)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0046

  Spike-in enhanced phosphoproteomics uncovers synergistic signaling responses to MEK inhibition in colon cancer cells

  • Matthias Selbach (Berlin / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0047

  Phosphoproteomic delineation of platelet activation states

  • Eva Smit (Amsterdam / NL)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0048

  Multiproteomics approach reveals an axonogenesis and synaptogenesis disruption throughout congenital Zika syndrome progression

  • Patricia Sosa-Acosta (Rio de Janeiro / BR)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0049

  Proteome-wide analysis of PTM-dependent protein conformational changes

  • Damiano Tosolini (Berlin / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0050

  Pitfalls in phosphoproteomic data analysis

  • Christine von Toerne (Munich / DE)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0051

  Deep learning-assisted lactylprotein mining (DeepLaM) identifies potential pan-cancer biomarkers

  • Ning Wan (Nanjing / CN)
  • Hui Ye (Nanjing / CN)

   Defining Signaling Networks - Functional PTMs
• • Poster presentation
  • P-I-0053

  Quantitative phosphoproteomics identifies filamin C as a signaling hub of MAP kinases in skeletal muscle cells during acute mechanical stress

  • Johannes P. Zimmermann (Wuerzburg / DE)

   Defining Signaling Networks - Functional PTMs